ZELLUNA ASA
Pioneering TCR-NK cell therapies to eliminate solid cancers effectively.
Yleiskatsaus
- 8
- Työntekijät
- Tuntematon
- Liikevaihto
- 2011
- Perustettu
Avainpäättäjät
Namir Hassan
Chief Executive Officer
Anders Tuv
Managing Director Radforsk Invest
Geir Christian Melen
Chief Financial Officer
Luise Weigand
Chief Scientific Officer
+15 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Zelluna ASA is a biotechnology company focused on pioneering novel cell therapies for cancer treatment. Their primary mission is to eliminate solid cancers, which represent the largest cancer burden globally. They are developing a unique and proprietary TCR-NK (T cell receptor guided natural killer)...